Bio Essence Corp Income Statement
BIOE|5 years of annual SEC 10-K data (FY2021-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$2M
FY2025
Gross Profit
$1M
75.3% gross margin
Operating Income
$900,011
FY2025
Net Income
$896,197
FY2025
Bio Essence Corp reported $2M in revenue and $896,197 in net income for FY2025. Revenue has grown at a 20.9% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 8/9 criteria passed
- Negative shareholders equity: Liabilities exceed assets
- Cash-backed earnings: Operating cash flow exceeds net income
- Profit margin: 47.2% of revenue retained as profit
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.9M | $323.9K | $551.5K | $621.6K | $888.0K |
| Cost of Revenue | $469.2K | $106.9K | $274.1K | $293.3K | $91.8K |
| Gross Profit | $1.4M | $217.1K | $277.4K | $328.3K | $298.3K |
| SG&A Expense | $497.8K | $676.5K | $345.6K | $763.1K | $1.1M |
| Operating Income | $900.0K | -$459.4K | -$345.6K | -$511.1K | -$857.5K |
| Interest Expense | - | - | $17.3K | $14.1K | $38.6K |
| Income Tax | $800 | $800 | $1.6K | $2.5K | $3.3K |
| Net Income | $896.2K | -$1.3M | -$971.9K | -$809.7K | -$647.6K |
| EPS (Basic) | - | -$0.03 | -$0.02 | -$0.02 | - |
| EPS (Diluted) | - | -$0.03 | -$0.02 | -$0.02 | -$0.02 |
| Shares Outstanding | 38.0M | 38.0M | 33.0M | 33.0M | 33.0M |
| Gross Margin | 75.3% | 67.0% | 50.3% | 52.8% | 33.6% |
| Operating Margin | 47.4% | -141.8% | -62.7% | -82.2% | -96.6% |
| Profit Margin | 47.2% | -404.0% | -176.2% | -130.3% | -72.9% |